- Home
- OST vs TCBP Comparison
OST vs TCBP Comparison
Compare OST & TCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OST
- TCBP
- Stock Information
- Founded
- OST 2010
- TCBP 2013
- Country
- OST China
- TCBP United Kingdom
- Employees
- OST 226
- TCBP N/A
- Industry
- OST Industrial Machinery/Components
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OST Technology
- TCBP Health Care
- Exchange
- OST Nasdaq
- TCBP Nasdaq
- Market Cap
- OST 3.6M
- TCBP 3.0M
- IPO Year
- OST 2022
- TCBP 2022
- Fundamental
- Price
- OST $0.24
- TCBP $0.68
- Analyst Decision
- OST
- TCBP
- Analyst Count
- OST 0
- TCBP 0
- Target Price
- OST N/A
- TCBP N/A
- AVG Volume (30 Days)
- OST 497.7K
- TCBP 3.0M
- Earning Date
- OST 08-26-2024
- TCBP 11-29-2024
- Dividend Yield
- OST N/A
- TCBP N/A
- EPS Growth
- OST N/A
- TCBP N/A
- EPS
- OST N/A
- TCBP N/A
- Revenue
- OST $38,203,634.00
- TCBP N/A
- Revenue This Year
- OST N/A
- TCBP N/A
- Revenue Next Year
- OST N/A
- TCBP N/A
- P/E Ratio
- OST N/A
- TCBP N/A
- Revenue Growth
- OST N/A
- TCBP N/A
- 52 Week Low
- OST $0.22
- TCBP $0.56
- 52 Week High
- OST $1.07
- TCBP $138.00
- Technical
- Relative Strength Index (RSI)
- OST 38.73
- TCBP 23.01
- Support Level
- OST $0.25
- TCBP $1.05
- Resistance Level
- OST $0.28
- TCBP $1.25
- Average True Range (ATR)
- OST 0.06
- TCBP 0.22
- MACD
- OST -0.01
- TCBP 0.06
- Stochastic Oscillator
- OST 5.95
- TCBP 10.36
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.